SequelSEC

STRYKER CORP SYK

Surgical & Medical Instruments & Apparatus · CIK 0000310764 · Fiscal year ends 1231

Revenue
$25.84B
Fiscal year ended 2026-06-30
Operating income
$5.53B
Fiscal year ended 2026-06-30
Free cash flow
$4.70B
Fiscal year ended 2026-06-30

STRYKER CORP (SYK) reported revenue of $25.84B and net income of $3.73B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from STRYKER CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

STRYKER CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$25.84B
Cost of revenue$9.05B
Gross profit$16.79B
Operating income$5.53B
Net income$3.73B
Research & development$1.66B
Weighted-average diluted sharesUnavailable
Pretax income$5.15B
Income tax expense$1.42B
Diluted EPS$9.65
Selling, general & administrative$8.78B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

STRYKER CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$3.39B
Total assets$47.93B
Current assets$14.42B
Total liabilities$23.94B
Current liabilities$6.68B
Total equity incl. NCI$23.99B
Temporary (mezzanine) equityUnavailable
Inventory$5.52B
Accounts receivable$3.74B
Goodwill$19.58B
Long-term debt$14.19B
Accounts payableUnavailable

Cash flow

STRYKER CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$5.52B
Capital expenditures$823.00M
Investing cash flow-$1.45B
Financing cash flow-$3.04B
Net change in cash$1.02B
Stock-based compensation$251.00M
Common dividends paid$1.32B
Common share repurchasesUnavailable
Depreciation & amortization$1.62B

Derived

STRYKER CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$4.70B
Gross margin65.0%
Operating margin21.4%
FCF margin18.2%
SBC / revenue1.0%
Current ratio2.16x
Revenue YoY growth8.5%
Net margin14.4%
R&D / revenue6.4%
CapEx / revenue3.2%
Long-term debt / equity0.59x
Effective tax rate27.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SYK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
10-Q · Filed 2025-05-02View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.